ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000573.1|Caulonodin_1 # 1 # 2946 # 1 # ID=1_1;partial=10;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.662	BGC0000573.1|Caulonodin_1 	1	2946	+	Loose	550	28.1054	SHV-191	31.15	3003591	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	SHV beta-lactamase	ATGAACACCGGACTTTTCACGACACGTCACGCGCTGGTCGCCAGCGCCGCCGTTCTGGCGATCACCGCGGCCGCGCCCGCTTGGGCCCAGCCGGCCACGCGCGACTATGACCTGGCCGCCCAGCCTCTAGGTCAGGCCCTAGGCCAAGTGGCTCGCCTCAGCGGCCGGCAGATCGTCGCCCCGACCGCCCTGGTGGCGGGCAAGACCGCCCCGGCCTTGAAGGGTCGCTACACCGCAGATCAGGCCTATGAGATCCTGCTGGCCGGATCGGGCCTGAAGCTCACCCCGGTCGGCGACATGCTGGTCGTGCAATCGGGCGCGGCAAACGCCCAGGGGGAGCCTTCGCCCGCCGACGCTGAGCGCGTGACCGAGGTCGTCGTCACCGGCACCCGGATCCGTGGCGCGGCGCCGGTGGGCTCCAACGTCATCTCCATCGGGCGCGCGGAAATCGACCGGGGCGGTTACGCCACGGCGCAGCAGATCCTGCAGGCTGTGCCCCAGAACTTCGGCGGCGGGCCGAACGAAACGACGTCAGGCTATAGCAGCCGCAACGGCGCCCCTAACAACACGAGCTTCGGTTCAGGGATCAACCTTCGCGGCCTAGGCGCTAATTCCACGCTGGTTCTGATCAACGGCAGCCGGCCGGCGGGCGGCGGCGTCGCTGGCATCTTCGCCGACATCTCGATCATTCCCGCTTCCGCGCTGGAGCGAGTCGAAGTGCTGCCTGACGGCGCATCGGCGCTCTACGGCTCGGACGCGGTGGGCGGTGTGGTCAATTTCGTGATGCGCGACGACTTCGACGGCCTTGAAACCCGTCTGCGCTACACCAGCGCCGACGGCGACGCTCGCGAGGCCCAAGCTTCCGCCCTTTGGGGCAAGCGCTGGGCGAGCGGGAGCATCACGGCCGCCTACGAATTTTACGATCGCGACGCCCTGGCCGCCACCCATCGGGGCTTTGCTACCGAGGATCTACGAAGCTTCGGCGGCGCGGACTATCGTCGCGCCTTCGCCGCGCCCGGCACGCTGATGGTCTCGGGCCAGGCCTTCGCGATCCCTCGTGGCCAGAACGGTCGTGGCCTTACCGCCGGGCAGTTGATCCCCGGGCAGCAGAACAAGGCCGACGAGCAGCGCGACACGGATCTGCTGCCTGCTCAGCAGCGCCAGAGCCTCTACCTGTCGGTCAAACAAGATCTTCGGACGGACGCCAGGCTCTTTGGCCAAGTGCTGATCGCGGGCCGGAATTTTGATCGCAGAGTTACCGGCAGCAGCCAGCGCACAGTGATCGTGCCCGCCGCCAACCCGTTCTACCTTAACCCACTGGGCGGCACGGCGCCCGTCTCGATGCAGTATGACTTCAGAGGTGACCTGGGCACGCCTCGGACCAGCGGACGGGTTCGCGCCTATAATGGCCTTGCCGGCGTTTCTCAGGATTTCGGCGCTTGGTCGGCGACGGGGCAACTGGGTTACGGGTTGCAGCGTGAGCTTTATCGCACCGACAACGGCGTCAACACCTACCGTCTCAATCAGGCGCTGGCCGACACCAATCCGGTGACCGCCTACAATGTGTTCGGCGATCCAGGCTCCACCAATCGCGCGACCATCGATGCGGTGCGCGGTTATTCCGGCGCCCGCACTCGGTTCGAAACCTGGTCTGCGGCCGTGCGCGCCGATGGGCCGCTGATGTCGTTGCCGGCCGGTGACCTGAAACTCGCGGCCGGGGCCGAGTGGCGCTCCGAACGTTTCGAGCAGCAGTTCGTGACCTATCTGAGCGCGGCCTCGCGGCTGCGGACCGACGCGAGCTATCCGGGCACGCGCAACATCACGGCCGGCTACGCCGAATTGCGCGTCCCCCTGATCGCCGCGACGATGAACGTTCCAGCGATCCGACAGCTCGATCTTTCGCTTGCCGGCCGGGTCGAGCGCTACAGCGACGTGGGCACGACCGCCAATCCGAAGGTCGGCGTCGATTGGCGCCCCACCTCGACCCTGACGCTGCGCGGCAGCTTCGGCACCTCGTTTCGAGCCCCCAGCTTTCAGGATCTGCAAACCGGGCCTGCCGTCACCGGCTATCAGCCGATCGTCGTGACCGATCCGAAGTCGCCCACCGGCAGTTCCACGGTGCTCGCCATACTAGGCAACTCACCCGACATGGGGCCGGAAAAGGCGACGACCTGGACCGGGGGCTTGACCTACCAGCCGCGGGCCGTGCCCGGCTTGACCGTGACGGCCGGCTATTTCGATGTCCGCTACAAGGACCGCATCGCCAATGTGAACGCCAATGCGTACAATCTTCTGATCCAGCGCGACGTCTACGCCGACGTGATCACCGAGGCCCCGTCCGCGGCCGTGGTCGCGGCCTATTACGCCAGCCCGCTGTTCTACAATCCGACCAACATTCCCGCCTCAGCCATCACTGCTCTGATCGACCTGGAGAACCGCAATCTCTCCGAGGTCCGCCAACGCGGTGTCGACTTCGACATCGGCTACGAAATGCGGTCGGACCTGGGCCTGTTTACCATCGGCCTTGGCGGCACACGAATTCTTGCCCTCGACCAGAAGGTCACCGCACGCTCGGCGCCCGTCGACGTCGTCGGAACCGTCGGGAACCCAGCCGCTCTGCGCCTGAGAGCTCGAACGACATGGTCGCAAGGTCCCTGGTCGGCGGCGGCTTTCGCCAATTTCATCAGCGACTATCAAAACCAACTCGTCACGCCACGCCAGCGGGTTAAATCCTGGACAACCGCGGATGTGCAAATCGCCTATCGCGTGTCGGACAGCGCCCCGCGCCTAGCTGGCGTCAGGCTGGCCCTAACGGTGAGCAATCTCTTCGACCGAGCTCCGCCCTTCGTCGAGTATCGAACCGTCACCTCGGCCCTGGGCTATGACGGCGAAAAGGCCGACCCCACCGGCCGCCGCATCGGCCTCGAAGTGGTGAAGTCCTGGTGA	MNTGLFTTRHALVASAAVLAITAAAPAWAQPATRDYDLAAQPLGQALGQVARLSGRQIVAPTALVAGKTAPALKGRYTADQAYEILLAGSGLKLTPVGDMLVVQSGAANAQGEPSPADAERVTEVVVTGTRIRGAAPVGSNVISIGRAEIDRGGYATAQQILQAVPQNFGGGPNETTSGYSSRNGAPNNTSFGSGINLRGLGANSTLVLINGSRPAGGGVAGIFADISIIPASALERVEVLPDGASALYGSDAVGGVVNFVMRDDFDGLETRLRYTSADGDAREAQASALWGKRWASGSITAAYEFYDRDALAATHRGFATEDLRSFGGADYRRAFAAPGTLMVSGQAFAIPRGQNGRGLTAGQLIPGQQNKADEQRDTDLLPAQQRQSLYLSVKQDLRTDARLFGQVLIAGRNFDRRVTGSSQRTVIVPAANPFYLNPLGGTAPVSMQYDFRGDLGTPRTSGRVRAYNGLAGVSQDFGAWSATGQLGYGLQRELYRTDNGVNTYRLNQALADTNPVTAYNVFGDPGSTNRATIDAVRGYSGARTRFETWSAAVRADGPLMSLPAGDLKLAAGAEWRSERFEQQFVTYLSAASRLRTDASYPGTRNITAGYAELRVPLIAATMNVPAIRQLDLSLAGRVERYSDVGTTANPKVGVDWRPTSTLTLRGSFGTSFRAPSFQDLQTGPAVTGYQPIVVTDPKSPTGSSTVLAILGNSPDMGPEKATTWTGGLTYQPRAVPGLTVTAGYFDVRYKDRIANVNANAYNLLIQRDVYADVITEAPSAAVVAAYYASPLFYNPTNIPASAITALIDLENRNLSEVRQRGVDFDIGYEMRSDLGLFTIGLGGTRILALDQKVTARSAPVDVVGTVGNPAALRLRARTTWSQGPWSAAAFANFISDYQNQLVTPRQRVKSWTTADVQIAYRVSDSAPRLAGVRLALTVSNLFDRAPPFVEYRTVTSALGYDGEKADPTGRRIGLEVVKSW	MRYIRLCIISLLATLPLAVHASPQPLEQIKLSESQLSGRVGMIEMDLVSGRTLTAWRADERFPMMSTFKVVLCGAVLARVDAGDEQLERKIHYRQQDLVDYSPVSEKHLADGMTVGELCAAAITMSDNSAANLLLATVGGPAGLTAFLRQIDDNVTRLDRWETELNEALPGDARDTTTPASMAATLRKLLTSQRLSARSQRQLLQWMVDDRVAGPLIRSVLPAGWFIADKTGAGERGARGIVALLGPNNKAERIVVIYLRDTPASMAERNQQIAGIGAALIEHWQR	343.01	gnl|BL_ORD_ID|4588|hsp_num:0	5658			69	252	
BGC0000573.1|Caulonodin_2 # 2943 # 4985 # 1 # ID=1_2;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.650	BGC0000573.1|Caulonodin_2 	2943	4985	+	Loose	1750	29.6462	amrB	40.0	3002983	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGATCGGCGTTCTTGCCGCCCTGGCGGTCGCGGCTCAGCCGATCCCGACCCCATCGAGCCTCGTGGAAACCGTCGATCTATCGACGCCGGTGCTTTCGCCCGACGGCAAGACGGTCGCCTTCCGTCAAGGTCGCGCATCCCTGAACTCCAATCTCTATGAGCTCAGTTGGTGGACAGTCCCACTCGACGCCAGCACGCCGCCGCGCATGATCGCCGACGCAGGCTCAGCGCTCTGGAACTCGTCCGGCGGACCTGTGGTAGAAGCGGCGCAATGGTCTTCGGACTCGCTGTGGCTCTACTATCGCGCTTTGAAAGAGCAACAAGTCCAGGTCTGGCGATCCGATCGGCGAGGCGGCATGGGCGAGCCGGTGACGCGCGATGACGGCGATGTCGAGCGGTTTATTCTGAAAGGGGATCGCCTGGCCTATGCGGTCCGGGCGACGCGATCGCAGATTCTCGACGCCGAACGGGCCGCGTACGATCAAGGCGTTCTCATCGACGCCACCATTGATCCCTCGCAAAACCTGTTTTCCGCGATCGAGATCAACGGGCGAATGGCGAGCCAGCGATTTTCCGGCTCGTGGTTCCAGCGCTCGGGGATCTTGGGCGACGCCAGCCAGCGGATCAAGGCGATCGATCTGACGAACCTGAAACCCATCGACGCGCAGTTGGAGGTTCCCCAGGATCCGTCGGACAGGATCGATGTCTTTGCCCTGGAAAAGAGCCTTGGACCAGCGTCGGCGTCACCGTTCGGCCAGGTCAGCGTCACTTGGAGGCCGGGCGGTTCCGCCGTCCAGATCACCAATCCCGACGGCAGCAAGCTGACCTGCGAAACGCCGACCTGCCAGGCCGCCCGGCCTCTCTGGGCCGCATGGCGGCCTGGACGGGCACAGGTAGTGTTCGCCGCACGGGACGCAAGCCTGGGCACGGCCCTCTACCTGTGGACGCCGGCGCGGGCCGAGACCAAGACGATCACCTTGGACGCTGGGACATTGGACGGCGGCGCGTTCGCCCAACCCTGCAGCGTTGGGATCGCGAAGGTCGTCTGCGTCGTCGCCGACAGCCTGTCGCCACCACGGTTGGAGGCGATCGATCTTGGGTCAGGAGGCCGAACGATCCTTGCCGCTCCCAACGGGCCCCCACTGTCGCAGGACGAGCTGGTCGCCGAACGTCTGTCATGGAAGGATACGGCGGGGCGCCGTTTCACCGGCGTTCTGCTGCGGCCCCGGCGGGCCCGGCATCTGCCGTTGTTCGTCAACTACTATGCCTGCGCCGGCTATTTGCGCGGTGGCGTCGGCGATCAATTTCCATTCATGATCCTGGCCCAGGCGGGTATCGTCAGTCTCTGCGTCAACGAGACACGCGACGATTCCGGCGGTCAGGACTCCGTCGCCGACTATGAGGCCGGCCTGGCCGGCGTGCGCGCGGCGATCGACGATCTGGCGGACAGAGGCCTCATCGATCCCAGCAAGGTCGGCATGGGCGGGCTGAGCTTTGGCAGCGATGTGACCCTTTGGGTCGCGGCCCACTCATCCCTGCTGGCGGCGGCGTCGATTGCTTCGGTCCAAGTCGGCCCGGCCTACTATTGGCTGAACGGTGTCGCGGGGCGAGACACCCACGAGGGCCTGCGCCGGTTCTGGAAACTCGGACGGCTGGACGAAACGCCGGATCGTTGGAAGCTCGTCGCGCCGGCGCTACACGCCGATCAGATAAAGGCGCCGCTTCTAATGCAGCTGCCCGAGCAGGAATTTAGGCCGACCATCGACCTGTTCGCCGCGCTGTCGAACTCCACGACGCCGGTGGAATTCCACGTCTTCGCCCAAGAGCCCCACATCCTGACCCAGCCCAGGCATCGGCTGGCGGCATATGCCAGGAATGTCGATTGGTTCAGATTCTGGCTGCAGGACTATATGGACCCAAGCCCGGGAAAGGCGGATCAGTATCGGCGTTGGGAGGCGATGAGATCGGCCCAAGCCGCCGCGCTCGCCCAACCTCAGACATCCTCCCAGGATCGCACCCAGGACTCGACGTCGGCCAGGTAG	MIGVLAALAVAAQPIPTPSSLVETVDLSTPVLSPDGKTVAFRQGRASLNSNLYELSWWTVPLDASTPPRMIADAGSALWNSSGGPVVEAAQWSSDSLWLYYRALKEQQVQVWRSDRRGGMGEPVTRDDGDVERFILKGDRLAYAVRATRSQILDAERAAYDQGVLIDATIDPSQNLFSAIEINGRMASQRFSGSWFQRSGILGDASQRIKAIDLTNLKPIDAQLEVPQDPSDRIDVFALEKSLGPASASPFGQVSVTWRPGGSAVQITNPDGSKLTCETPTCQAARPLWAAWRPGRAQVVFAARDASLGTALYLWTPARAETKTITLDAGTLDGGAFAQPCSVGIAKVVCVVADSLSPPRLEAIDLGSGGRTILAAPNGPPLSQDELVAERLSWKDTAGRRFTGVLLRPRRARHLPLFVNYYACAGYLRGGVGDQFPFMILAQAGIVSLCVNETRDDSGGQDSVADYEAGLAGVRAAIDDLADRGLIDPSKVGMGGLSFGSDVTLWVAAHSSLLAAASIASVQVGPAYYWLNGVAGRDTHEGLRRFWKLGRLDETPDRWKLVAPALHADQIKAPLLMQLPEQEFRPTIDLFAALSNSTTPVEFHVFAQEPHILTQPRHRLAAYARNVDWFRFWLQDYMDPSPGKADQYRRWEAMRSAQAAALAQPQTSSQDRTQDSTSAR	MARFFIDRPVFAWVISLFIMLGGIFAIRALPVAQYPDIAPPVVSLYATYPGASAQVVEESVTAVIEREMNGVPGLLYTSATSSAGQASLSLTFKQGVSADLAAVDVQNRLKIVEARLPEPVRRDGISIEKAADNAQIIVSLTSEDGRLSGVELGEYASANVLQALRRVEGVGKVQFWGAEYAMRIWPDPVKMAALGLTASDIASAVRAHNARVTIGDVGRSAVPDSAPIAATVLADAPLTTPDAFGAIALRARADGSTLYLRDVARIEFGGNDYNYPSFVNGKTATGMGIKLAPGSNAVATEKRVRATMEELAKFFPPGVKYQIPYETASFVRVSMSKVVTTLVEAGVLVFAVMFLFMQNFRATLIPTLVVPVALLGTFGAMLAAGFSINVLTMFGMVLAIGILVDDAIVVVENVERLMVEEKLPPYEATVKAMKQISGAIVGITVVLTSVFVPMAFFGGAVGNIYRQFAFALAVSIGFSAFLALSLTPALCATLLKPVADDHHEKDGFFGWFNRFVARSTHRYTRRVGRVLERPLRWLVVYGALTAAAALLITKLPAAFLPDEDQGNFMVMVIRPQGTPLAETMQSVRRVEEYVRTHSPSAYTFALGGYNLYGEGPNGGMIFVTMKDWKERKRARDQVQAIIAEINAHFAGTPNTMVFAINMPALPDLGLTGGFDFRLQDRGGLGYGAFVAAREKLLAEGRKDPVLTDLMFAGTQDAPQLKLDIDRAKASALGVSMEEINATLAVMFGSDYIGDFMHGSQVRRVIVQADGRHRLDAADVTKLRVRNAKGEMVPLAAFATLHWTMGPPQLTRYNGFPSFTINGAASAGHSSGEAMAAIERIASTLPAGTGYAWSGQSYEERLSGAQAPMLFALSVLVVFLALAALYESWSIPFAVMLVVPLGVIGAVAGVTLRGMPNDIYFKVGLIATIGLSAKNAILIVEVAKDLVAQRMSLADAALEAARLRLRPIVMTSLAFGVGVLPLAFATGAASGAQIAIGTGVLGGVISATLFAIFLVPLFFVCVGRVFDVVPRRRGGAQAALEAK	65.20	gnl|BL_ORD_ID|428|hsp_num:0	476			1527	1623	
BGC0000573.1|Caulonodin_3 # 4937 # 6676 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.632	BGC0000573.1|Caulonodin_3 	4937	6676	-	Loose	810	28.8758	cdeA	27.27	3003835	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGGAGGACTACGTCGTCCTGATCTGGCCGGCTCTGGCCGAAGCGCCGGCGCGCGACCTCATACGTCGCTTGCCCAAGCTAAAGACGGTAATCGAAACGTCCGGCCTGGTTGTGCTCCGCCCCGAAAACGGCGCTGGCCTGCGCGTTGGAGGCAATGGCGTCGTCCTTGGATCCGTCTTCCGAACAGGCGGAGATCGCGAAACCGTGGCGGAATTTTCGGAGTCCGAGGCCTCGGCGATCGCGACGTCGCGCGGACAGCAGCTGGTCACCGAGTTTTGGGGCGGATACCTCGCGGTCTTGGGGGACGCGAGCCGGTCCGAGGTTATGGTTCTTCGCGACCCTTCCGGCGCGATGCCGGCCTATTGCTTGGTTCATGGCGAGGTTCAGATCATCTGCTCTCGTCTCGAAGTGCTCGAGGACGCGGGCTTGGGCCAGCAAGCCCTGAACTGGGACGTCGTGGCGCAACTTCTGGCGTTTCCAAACCTGCGCGGCCGATCCACGGGATTGAAAGGTGTTGAGGAGCTTCTGCCGGGCTGTCGCCTAACGTTCACAGGTGGGTTGAAGACGGAAACGTTGACTTGGAACCCCTGGCTTTTCGCCCGCCCGAGCGCTCAGGCGCCAGAGCGGGGAGTCGCAGCCACGGCGGTGCGTCAGGCGGTTGAGGTAAGCGTCCGCAAATGGGCGGACCAGTCGTCGCCAGTGCTTCTCGAACTTTCCGGCGGGTTGGATTCTTCGATCATTGCCTGCTGTCTGGACGAGCCGCGCACGGCCGCAACCTTCGTAAATTTCGTCACCCCGACGGCGGAAGGCGATGAGCGCGGCTATGCGCGCCTGGTCGCCAAAGCCGCTGACAAACAGCTTATCGAGCAGGATATCAGGGCCGATGAGGTGGATGTGACTCGGCCGCGCCCGGGGCGCCATCCCAGGCCCGCCTCACAGGCGCTCTTGCAGCCGTTGGAACAAGCTTGCGCTGAGCTAGCGCCACAGCTTGGCGCCCGATCATTCTTCAGCGGCCTAGGTGGGGACAACGTCTTCTGTTCTATCGCCACGGCAAGTCCCGCCGCCGACGCCTTGTTGACCTCTGGTCTAGGGCGCCAATTTTGGGCGGCCATCGGCGATTTGTGCGCCCGGCACAACTGCACCGTCTGGGCTGCTCTCTCGGCGACTTTGAAGAAGCTGCTGCGGTCTGACCGTCGTCTCGTGATCAAGCCGAACCTGGATTTTCTGTCCTTCAGAGAAGACGCAATCGATCGGCCCGATCACCCGTGGCTCGAGGTTGCCGCAGATCGTCTTCCCGGCAAGCGCGAGCATGTCGCCAGCATTCTGCTGGCCCAGGGATTCTTGGACCGTTACGAGCATGCCCAGGTCGCGGCCGTGCGCTTCCCGCTACTGACTCAGCCAGTGATGGAAGCTTGCCTGCGTGTTCCAACTTGGATGGCTAATCACCAGGGACGTAACCGCGCGGTGGCGCGAGACGCCTTCTTTGACCGCCTCCCTCCGCGCGTGCGCGATCGCCAGACCAAAGGAGGCCTGAACGCCTTCATGGGCGTGGCGTTCGAGCGCAATCGACAAGCTCTGGCTCGGCACCTGTTGGACGGAAGGCTGGTCCAGCGTGGCCTGATCGACGCCGTCGCCATAAAAAGCGCCTTGGCCTCGCCCGTCCTTGAGGGCGGGGCTATGAATAGGCTGCTCTACCTGGCCGACGTCGAGTCCTGGGTGCGATCCTGGGAGGATGTCTGA	MEDYVVLIWPALAEAPARDLIRRLPKLKTVIETSGLVVLRPENGAGLRVGGNGVVLGSVFRTGGDRETVAEFSESEASAIATSRGQQLVTEFWGGYLAVLGDASRSEVMVLRDPSGAMPAYCLVHGEVQIICSRLEVLEDAGLGQQALNWDVVAQLLAFPNLRGRSTGLKGVEELLPGCRLTFTGGLKTETLTWNPWLFARPSAQAPERGVAATAVRQAVEVSVRKWADQSSPVLLELSGGLDSSIIACCLDEPRTAATFVNFVTPTAEGDERGYARLVAKAADKQLIEQDIRADEVDVTRPRPGRHPRPASQALLQPLEQACAELAPQLGARSFFSGLGGDNVFCSIATASPAADALLTSGLGRQFWAAIGDLCARHNCTVWAALSATLKKLLRSDRRLVIKPNLDFLSFREDAIDRPDHPWLEVAADRLPGKREHVASILLAQGFLDRYEHAQVAAVRFPLLTQPVMEACLRVPTWMANHQGRNRAVARDAFFDRLPPRVRDRQTKGGLNAFMGVAFERNRQALARHLLDGRLVQRGLIDAVAIKSALASPVLEGGAMNRLLYLADVESWVRSWEDV	MENLFTRKFTTFEFLKFVSPAIISMIFISLYTIIDGIFVSTLVGSDALASINIVLPIINLVCGFGIMMATGGGAIVSIRMGENRQDEANSTFSFIVLFSLIVGILFTVISYFFIKEISILLGATDKLLPYCITYGKVMILCTPFYILKFIFEYFARTDGNSKFSLFLSVIGGVTNIILDYVFIKYFGMGLLGAAVATAIGIILTCVLGIIYFLSNKSTLKLRKPKTDFRLIRDTMINGSSEMVTELSTGITTFLFNVVALKLAGENGLAALTIVLYAHFLMTSVYLGFAAGVSPLISYNFGAENSDKLKETFKHSLKFIFISSLLVFIIALVFAPFIVRVFVNPDNTVFKLALQGLKIFAFAFLFVGINIFASGFFTAFHNGKISAIISFSRAFVFIIIGIIILPPMLNMTGLWLTVPFAEVITIFISILFIKKYKGRYKY	131.29	gnl|BL_ORD_ID|2083|hsp_num:0	2321			345	444	acriflavine
BGC0000573.1|Caulonodin_4 # 6676 # 7335 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.621	BGC0000573.1|Caulonodin_4 	6676	7335	-	Loose	500	26.5646	OXA-22	40.0	3001417	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGCGCGTAGCCGTTCCCGATCATCTCGCATACTGCGTAAAGCAAGGTGGCGTCACGTTTCTGGATGTTCGTGGCGACCGCTATTTCGGTCTACCGCCGGTGCTCGAACACGCCTTCGTCGCGATCGCCGAGGCAGACTTCCTTCTGAAAGAGCCGAACTCGCTCTTGGAGCCACTGGAGGCCCTTGGCGTGCTTGTTCGAGGTCAGGCGCGGCGCGCGGATCTGACGATCCCGTCGGCAAATCTAAGCTGGGTGGACGAGGTCTCTCCGACGCCGCCTCGACTTGACCCAGCAAGCCTGGTCGCCACGGTTACGTCCGTCATACGGACTCGGCTGTCGCAGAAGTCGAAATCATTGCAAGCGTTGCTGGAGGAGGTCAGGACGCGGCGGCCAGGGTCACCCGCCCATAACTGGCAGCTGATGCGTCGCTTGACTGCGGGGTTTCGCGCCAGCCGGGCTTGGGCACCGATCGAGCCGATTTGCCTGCTGGACTCCCTGGCCCTGCTCGACTTCCTTCACCGACGAGGTCTCTACCCGCACATCGTCTTTGGCGTCATACGCCAACCTTTCGCTGCCCACTGCTGGGTTCAAGCCGACGACGTCGTGCTGAACGATCGGCTCGATCACGTCGGCGAATACACGCCGATCCTGGTCGTGTAA	MRVAVPDHLAYCVKQGGVTFLDVRGDRYFGLPPVLEHAFVAIAEADFLLKEPNSLLEPLEALGVLVRGQARRADLTIPSANLSWVDEVSPTPPRLDPASLVATVTSVIRTRLSQKSKSLQALLEEVRTRRPGSPAHNWQLMRRLTAGFRASRAWAPIEPICLLDSLALLDFLHRRGLYPHIVFGVIRQPFAAHCWVQADDVVLNDRLDHVGEYTPILVV	MKRRHAAIGALLAALATFAHAEHPICTIVADAATGKAVLHEGKCDERVTPASTFKLALAVMGFDHGFLKDEHTPVEHFRHGDPDWGGEAWHQPIDPALWLKYSVVWYSQRITHAMGAQTFQAYVRKLGYGNMDVSGDPGKNNGMDRSWITSSLKISPEEQVGLMRRIVNRQLPVSAHTYEMLDRTVQTWQVPGGWAVQGKTGTAGPAPGNTSPDGTWDQAHAYGWFVGWARKGDKTYVFANLIQDDKVEPTSGGIRSRDALFARLSEVLAFAGH	79.93	gnl|BL_ORD_ID|639|hsp_num:0	693			636	753	cloxacillin; oxacillin; cefalotin
BGC0000573.1|Caulonodin_5 # 7377 # 7511 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.570	BGC0000573.1|Caulonodin_5 	7377	7511	-	Loose	2000	21.9422	oqxB	35.48	3003923	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; glycylcycline; tetracycline antibiotic; diaminopyrimidine antibiotic; nitrofuran antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGAATTTGAAGGCATCCCTTCCCCGGACGCGCGGATCGATCTCGGCTTAGCGAGTGAAGAAACCTGCGGCCAAATCTACGATCACCCCGAAGTGGGCATCGGCGCTTATGGTTGCGAAGGATTGCAGCGGTGA	MEFEGIPSPDARIDLGLASEETCGQIYDHPEVGIGAYGCEGLQR	MDFSRFFIDRPIFAAVLSILIFITGLIAIPLLPVSEYPDVVPPSVQVRAEYPGANPKVIAETVATPLEEAINGVENMMYMKSVAGSDGVLVTTVTFRPGTDPDQAQVQVQNRVAQAEARLPEDVRRLGITTQKQSPTLTLVVHLFSPGGKYDSLYMRNYATLKVKDELARLPGVGQIQIFGSGEYAMRVWLDPNKVAARGLTASDVVTAMQEQNVQVSAGQLGAEPLPQESDFLISINAQGRLHTEEEFGNIILKTAQDGSLVRLRDVARIEMGSGSYALRSQLNNKDAVGIGIFQSPGANAIDLSNAVRAKMAELATRFPEDMQWAAPYDPTVFVRDSIRAVVQTLLEAVVLVVLVVILFLQTWRASIIPLIAVPVSVVGTFSILYLLGFSLNTLSLFGLVLAIGIVVDDAIVVVENVERNIEEGLAPLAAAHQAMREVSGPIIAIALVLCAVFVPMAFLSGVTGQFYKQFAVTIAISTVISAINSLTLSPALAALLLKPHGAKKDLPTRLIDRLFGWIFRPFNRFFLRSSNGYQGLVGKTLGRRGAVFAVYLLLLCAAGVMFKVVPGGFIPTQDKLYLIGGVKMPEGSSLARTDAVIRKMSEIGMNTEGVDYAVAFPGLNALQFTNTPNTGTVFFGLKPFDQRKHTAAEINAEINAKIAQIQQGFGFSILPPPILGLGQGSGYSLYIQDRGGLGYGALQSAVNAMSGAIMQTPGMHFPISTYQANVPQLDVQVDRDKAKAQGVSLTDLFGTLQTYLGSSYVNDFNQFGRTWRVMAQADGPYRESVEDIANLRTRNNQGEMVPIGSMVNISTTYGPDPVIRYNGYPAADLIGDADPRVLSSSQAMTHLEELSKQILPNGMNIEWTDLSFQQATQGNTALIVFPVAVLLAFLVLAALYESWTLPLAVILIVPMTMLSALFGVWLTGGDNNVFVQVGLVVLMGLACKNAILIVEFARELEIQGKGIMEAALEACRLRLRPIVMTSIAFIAGTIPLILGHGAGAEVRGVTGITVFSGMLGVTLFGLFLTPVFYVTLRKLVTRRKPVQEDLPA	4.19	gnl|BL_ORD_ID|2152|hsp_num:0	2400			804	897	tigecycline; ciprofloxacin; nitrofurantoin; trimethoprim
BGC0000573.1|Caulonodin_6 # 7575 # 7709 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.681	BGC0000573.1|Caulonodin_6 	7575	7709	-	Loose	300	21.9422	dfrA15b	32.0	3004640	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGCAACGGATCATCGACGAGACCACGGACGGTCTGATCGAGCTGGGCGCTGCAAGCGTGCAGACCCAGGGCGATGTCCTCTTCGCGCCCGAGCCGGGCGTCGGCCGCCCGCCCATGGGCCTGTCGGAAGACTAG	MQRIIDETTDGLIELGAASVQTQGDVLFAPEPGVGRPPMGLSED	MKLSLMAAISKNGVIGNGPDIPWSAKGEQLLFKAITYNQWLLVGRKTFESMGALPNRKYAVVTRSSFTSSDENVLVFPSIDEALNHLKTITDHVIVSGGGEIYKSLIDKADTLHISTIDIEPEGDVYFPEIPGSFRPVFSKDFVSNINYSYQIWQKG	28.03	gnl|BL_ORD_ID|2121|hsp_num:0	3339			336	411	trimethoprim
BGC0000573.1|Caulonodin_8 # 8036 # 8791 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.702	BGC0000573.1|Caulonodin_8 	8036	8791	-	Loose	500	26.9498	MYX-1	48.57	3006955	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MYX beta-lactamase	ATGGATCAGCCTGCTCAAGCGGGCATGATCAGCGCCAGTAAGCGGCGTTCGATGCGCCGGTCCGGTCGGGGCCGCGCGACGCCGGGCGTGCGTGCCGCCAACCTGGATCGCGCCGCCAAGGGAGCGGCCATGATCGAACGCGCGGGCACAGGCGAGCGAGTCTATCTCGCCATCAAGACCTTCTTGTTGACCGAGAGCGATCACCGACCTGGCGAGCGCATCGAGGTCGCCGACCTCTCGCGCCGTTTCGGGGCCAGCGCCACGCCGGTGCGCGCCGCGCTCCACCGCTTGGCCGGCGAGCGCCTGCTGGTCAGTCACCAGGGCGAGGGCTTCTCGGTGCCGCGCGTCACCGAGCCGGGTCTGACCGATCTCTACCAATGGAACGCCGCCTTGCTGGTCAACGCCATGCGCTCGACGCCGAGCCAGGCGCCGCCGCCAACGGCGCCCGACTTCGATCCGGACCACCCGATCCTCTATCTTGAGGGGGTCTTCGCGGCCTTGGCCGCTCACTGCCAGAACATCGAGGTTGAATGGGCCGTCGCCGGCGCGAACGATCGGCTGCATCGCGCGCGGCGGGCCGAGCGGGCCTTGGCGCCCGAGTTCGCCGATGAGGCGCGCGAGCTGGGCCAGCTCCTGGTCGCCGGCGACCACAACGGCCTTCGTCAGGCGATCGTCACCTATCACCGCAAGCGCCTACGCCTGGTTCCGGCCCTTGCGCGGCACCTCCATGGGCTGGGTGATCGGGAGCGCCGGTGA	MDQPAQAGMISASKRRSMRRSGRGRATPGVRAANLDRAAKGAAMIERAGTGERVYLAIKTFLLTESDHRPGERIEVADLSRRFGASATPVRAALHRLAGERLLVSHQGEGFSVPRVTEPGLTDLYQWNAALLVNAMRSTPSQAPPPTAPDFDPDHPILYLEGVFAALAAHCQNIEVEWAVAGANDRLHRARRAERALAPEFADEARELGQLLVAGDHNGLRQAIVTYHRKRLRLVPALARHLHGLGDRERR	MTLFPLRWFCAGALLITLSTACTRSTPAATVERNIPVKAQSQGPDEYVLADDVSVRKLAPGVWLHITVVTLEPFGRVSTNGLIIEDGETSLLVDTGWDARQGALLLDWARDTLRRPVRAAVVTHFHEDRLGGVPALAPHGIPVHGLEETARIATSLGLPGPTETFAKTSTVDSLELFFPGAGHAKDNIVVWHRDSGVLFGGCFVKDGASTNLGNVADADVAAWPASLSRTRQRFPEARVVVPGHGQPGGPELLGHTEALLR	96.17	gnl|BL_ORD_ID|3707|hsp_num:0	4777			348	453	
BGC0000573.1|Caulonodin_9 # 8823 # 9053 # -1 # ID=1_9;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.636	BGC0000573.1|Caulonodin_9 	8823	9053	-	Loose	600	23.0978	ROB-11	37.5	3007125	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	ROB beta-lactamase	ATGATCGAGACCCAGACCTTTCGTGTTCACGCCCGCGACGACGATCACAACCATGCCCACAGCGTGGACGCCGTCAGCTTCGAGGACGCCGCCGTGGCCTTCGTGGAGATGTGGCATCCGCCGGTTGACGCCGACAACGAGGTCTCGATCGTGGTGCGCCAGGTCGACAGCGGCGTAGAGCATTGTTTCCGCATCGATCTGGACAGCGGCCAGGCCGCGCCTTGCCAATAG	MIETQTFRVHARDDDHNHAHSVDAVSFEDAAVAFVEMWHPPVDADNEVSIVVRQVDSGVEHCFRIDLDSGQAAPCQ	MLNKLKIGTLLLLTLTACSPNSVHSVTSNPQPASAPVQQSATQATFQQTLANLEQQYQARIGVYVWDTETGHSLSYRADERFAYASTFKALLAGAVLQSLPEKDLNRTISYSQKDLVSYSPETQKYVGKGMTIAQLCEAAVRFSDNSATNLLLKELGGVEQYQRILRQLGDNVTHANRLEPDLNQAKPNDIRDTSTPKQMAMNLNAYLLGNTLTESQKTILWNWLDNNATGNPLIRAATPTSWKVYDKSGAGKYGVRNDIAVVRIPNRKPIVMAIMSTQFTEEAKFNNKLVEDAAKQVFHTLQLN	24.92	gnl|BL_ORD_ID|4804|hsp_num:0	5795			492	564	
